Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04298840

Influence of Creatine Monohydrate Supplementation on Androgens and Global Hair Assessments

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Texas Tech University · Academic / Other
Sex
Male
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

This study is a randomized, double-blind, placebo-controlled trial examining the effects of creatine monohydrate supplementation on androgens and hair loss in free-living adult males. Participants will complete 6 months of supplementation of 5 grams per day of creatine monohydrate while following their normal lifestyle practices. At baseline and six months after study initiation, participants will complete laboratory assessments. These assessments will include a standard blood draw for evaluation of total testosterone (T), free T, dihydrotestosterone (DHT), and DHT:T ratios in the blood, as well as global photography and questionnaires to evaluate hair loss. This study will examine the claim that creatine increases DHT concentrations and and DHT:T ratio, as well as provide novel data regarding whether creatine promotes hair loss.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCreatine Monohydrate SupplementationParticipants in the creatine monohydrate supplementation arm will consume 5 grams per day of creatine monohydrate.
DIETARY_SUPPLEMENTPlacebo SupplementationParticipants in the placebo supplementation arm will consume 5 grams per day of maltodextrin placebo.

Timeline

Start date
2020-04-01
Primary completion
2021-02-01
Completion
2021-02-01
First posted
2020-03-06
Last updated
2021-09-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04298840. Inclusion in this directory is not an endorsement.